Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients. (Q51357963)
Jump to navigation
Jump to search
scientific article published on 16 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients. |
scientific article published on 16 May 2012 |
Statements
1 reference
Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients. (English)
1 reference
V Pirags
1 reference
H Lebovitz
1 reference
P Fouqueray
1 reference
16 May 2012
1 reference
14
1 reference
9
1 reference
852-858
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference